Form D · Biotechnology
Genovel Orthopedics, Inc.
Herndon, VA · CIK 0001606358
Offering snapshot reported May 23, 2014 · SEC filing
- Reported sold
- $1M Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 14, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 23, 2014 | Initial | $1,000,050 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-217979
Common Stock was sold for an aggregate price of $50.00. Series A Common Stock was sold for an aggregate price of $1,000,000 plus contribution to the issuer of a license to certain technology.
Source: Form D, filed May 23, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cherine Plumaker | Director, Executive |
| David Present | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
460 Herndon Parkway, Suite 150
Herndon, VA, 20170
Herndon, VA, 20170